These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33333640)

  • 1. [In vitro evaluation of the antibacterial activity of nemonoxacin against
    Jiang GL; Wang F; Xue Y; Jia JN; Huang HR
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Dec; 43(12):1061-1065. PubMed ID: 33333640
    [No Abstract]   [Full Text] [Related]  

  • 2. [
    Li B; Guo Q; Chu HQ
    Zhonghua Jie He He Hu Xi Za Zhi; 2021 Nov; 44(11):947-952. PubMed ID: 34758520
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative antimicrobial activities of the newly synthesized quinolone WQ-3034, levofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Tomioka H; Sato K; Kajitani H; Akaki T; Shishido S
    Antimicrob Agents Chemother; 2000 Feb; 44(2):283-6. PubMed ID: 10639351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GenoType NTM-DR Performance Evaluation for Identification of Mycobacterium avium Complex and Mycobacterium abscessus and Determination of Clarithromycin and Amikacin Resistance.
    Huh HJ; Kim SY; Shim HJ; Kim DH; Yoo IY; Kang OK; Ki CS; Shin SY; Jhun BW; Shin SJ; Daley CL; Koh WJ; Lee NY
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nemonoxacin has potent activity against gram-positive, but not gram-negative clinical isolates.
    Li ZX; Liu YN; Wang R; Li AM
    Clin Ter; 2015; 166(6):e374-80. PubMed ID: 26794819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic mutations in linezolid-resistant Mycobacterium avium complex and Mycobacterium abscessus clinical isolates.
    Kim SY; Jhun BW; Moon SM; Jeon K; Kwon OJ; Huh HJ; Lee NY; Shin SJ; Daley CL; Koh WJ
    Diagn Microbiol Infect Dis; 2019 May; 94(1):38-40. PubMed ID: 30581010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of amikacin against isolates of Mycobacterium avium complex with proposed MIC breakpoints and finding of a 16S rRNA gene mutation in treated isolates.
    Brown-Elliott BA; Iakhiaeva E; Griffith DE; Woods GL; Stout JE; Wolfe CR; Turenne CY; Wallace RJ
    J Clin Microbiol; 2013 Oct; 51(10):3389-94. PubMed ID: 23946523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vitro activity of quinolones and macrolides against mycobacteria.
    Yew WW; Piddock LJ; Li MS; Lyon D; Chan CY; Cheng AF
    J Antimicrob Chemother; 1994 Sep; 34(3):343-51. PubMed ID: 7829409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of non-tuberculous mycobacteria among tuberculosis patients, a study from a tertiary care hospital in Lahore, Pakistan.
    Karamat A; Ambreen A; Ishtiaq A; Tahseen S; Rahman MA; Mustafa T
    BMC Infect Dis; 2021 Apr; 21(1):381. PubMed ID: 33894767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH; Liu CY; Lu JJ; King CH; Hsueh PR
    J Antimicrob Chemother; 2009 Dec; 64(6):1226-9. PubMed ID: 19833635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates.
    Kobashi Y; Yoshida K; Miyashita N; Niki Y; Oka M
    J Infect Chemother; 2006 Aug; 12(4):195-202. PubMed ID: 16944258
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Luo J; Yu X; Jiang G; Fu Y; Huo F; Ma Y; Wang F; Shang Y; Liang Q; Xue Y; Huang H
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29760127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophostin and Cyclipostins analogues, new promising molecules to treat mycobacterial-related diseases.
    Nguyen PC; Madani A; Santucci P; Martin BP; Paudel RR; Delattre S; Herrmann JL; Spilling CD; Kremer L; Canaan S; Cavalier JF
    Int J Antimicrob Agents; 2018 Apr; 51(4):651-654. PubMed ID: 29241819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Tomioka H; Sato K; Akaki T; Kajitani H; Kawahara S; Sakatani M
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3001-4. PubMed ID: 10582897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bedaquiline/clofazimine combination regimen might add activity to the treatment of clinically relevant non-tuberculous mycobacteria.
    Ruth MM; Sangen JJN; Remmers K; Pennings LJ; Svensson E; Aarnoutse RE; Zweijpfenning SMH; Hoefsloot W; Kuipers S; Magis-Escurra C; Wertheim HFL; van Ingen J
    J Antimicrob Chemother; 2019 Apr; 74(4):935-943. PubMed ID: 30649327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antimicrobial susceptibility and genotyping of
    Wang SQ; Jiang GL; Wei GM; Huo FM; Dong LL; Zhao LP; Huang HR; Wang GR
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 Jul; 41(7):539-543. PubMed ID: 29996350
    [No Abstract]   [Full Text] [Related]  

  • 18. Multicenter study in Taiwan of the in vitro activities of nemonoxacin, tigecycline, doripenem, and other antimicrobial agents against clinical isolates of various Nocardia species.
    Lai CC; Liu WL; Ko WC; Chen YH; Tan HR; Huang YT; Hsueh PR
    Antimicrob Agents Chemother; 2011 May; 55(5):2084-91. PubMed ID: 21343461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).
    Saito H; Sato K; Tomioka H; Dekio S
    Tuber Lung Dis; 1995 Oct; 76(5):377-80. PubMed ID: 7495996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in-vitro activity of Bay y 3118, a new quinolone, and ciprofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex.
    Sirgel FA; Venter A; Heilmann HD
    J Antimicrob Chemother; 1995 Feb; 35(2):349-51. PubMed ID: 7759400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.